Annals of Diagnostic Pathology
Volume 10, Issue 4 , Pages 241-250, August 2006

Mesothelioma in patients with nonoccupational asbestos exposure:

An evidence-based approach to causation assessment

  • Alberto M. Marchevsky, MD

      Affiliations

    • Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 310 423 6611; fax: +1 310 423 6629.
  • ,
  • Philip Harber, MD

      Affiliations

    • Division of Occupational and Environmental Medicine, Department of Family Medicine, UCLA School of Medicine, Los Angeles, CA 90024, USA
  • ,
  • Lori Crawford, BS

      Affiliations

    • Division of Occupational and Environmental Medicine, Department of Family Medicine, UCLA School of Medicine, Los Angeles, CA 90024, USA
  • ,
  • Mark R. Wick, MD

      Affiliations

    • University of Virginia Health System, Charlottesville, VA 22906, USA

Abstract 

The specific parameters of nonoccupational asbestos exposures (NOAE) that can distinguish an idiopathic from an asbestos-caused malignant mesothelioma (MM) are controversial. A systematic literature review yielded 1028 cases with this putative association. Only 287 of those reports had a defined single exposure to a household, building occupant, or neighborhood/community asbestos source. The available “evidence” was used to develop semiarbitrary evidence-based causation guideline rules for the assessment of putative associations between MM and NOAE. The rules are classified into class A (tissue burden analysis shows asbestos body counts or fiber counts in lung tissues comparable to MM caused by occupational exposure to asbestos) and classes B to D based on whether certain combinations of NOAE features and MM (evidence) have been described in over 15% (class B), 5% to 15% (class C), and less than 5% (class D) of the patients reviewed. The proposed 4 classes of evidence-based causation guidelines provide a semiarbitrary framework to evaluate the causation of individual MM patients by NOAE based on decreasing levels of currently available evidence. The neoplasms in classes A to C patients are probably caused by NOAE, with decreasing weight of evidence in the 3 groups. There is minimal evidence to support the causation of MM by NOAE in class D patients. There is no evidence or only anecdotal evidence to support a causal association between MM and NOAE in individuals who cannot be classified into any of the 4 classes. Future studies are needed to provide more comprehensive data regarding the association between MM and NOAE.

Keywords: Mesothelioma, Asbestos, Causes of neoplasms, Evidence-based medicine

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1092-9134(06)00084-0

doi:10.1016/j.anndiagpath.2006.06.012

Annals of Diagnostic Pathology
Volume 10, Issue 4 , Pages 241-250, August 2006